Lemaitre Vascular (LMAT) Misses Q1 EPS by 2c, Raises FY 2018 EPS Guidance, Lowers FY 2018 Rev Guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.19, $0.02 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $0 versus the consensus estimate of $26.42 million.

GUIDANCE:

Lemaitre Vascular sees FY 2018 EPS of $1.05-$1.13. Lemaitre Vascular sees FY 2018 revenue of $106-109 million.

The company has forecasted EPS of $0.96-$1.00 and revenues of $110-111.6 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
• Pfizer's 25-valent pneumococcal vaccine shows Phase 2 results
• Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance